Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment naive patients with compensated cirrhosis: real-world experience from Taiwan HCV registry

Chao-Hung Hung; Te-Sheng Chang; Chung-Feng Huang; Hsing-Tao Kuo; Ching-Chu Lo; Chien-Wei Huang; Lee-Won Chong; Pin-Nan Cheng; Ming-Lun Yeh; Cheng-Yuan Peng; Chien-Yu Cheng; Jee-Fu Huang; Ming-Jong Bair; Chih-Lang Lin; Chi-Chieh Yang; Sih-Ren Wang; Tsai-Yuan Hsieh; Tzong-Hsi Lee; Pei-Lun Lee; Wen-Chih Wu; Chih-Lin Lin; Wei-Wen Su; Shengshun Yang; Chia-Chi Wang; Jui-Ting Hu; Lien-Juei Mou; Chun-Ting Chen; Yi-Hsiang Huang; Chun-Chao Chang; Jia-Sheng Huang; Guei-Ying Chen; Jian-Neng Gao; Chi-Ming Tai; Chun-Jen Liu; Mei-Hsuan Lee; Pei-Chien Tsai; Chia-Yen Dai; Jia-Horng Kao; Han-Chieh Lin; Wan-Long Chuang; Chiyi Chen; Kuo-Chih Tseng; Ming-Lung Yu

Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment naive patients with compensated cirrhosis: real-world experience from Taiwan HCV registry

Chao-Hung Hung, Te-Sheng Chang, Chung-Feng Huang, Hsing-Tao Kuo, Ching-Chu Lo, Chien-Wei Huang, Lee-Won Chong, Pin-Nan Cheng, Ming-Lun Yeh, Cheng-Yuan Peng, Chien-Yu Cheng, Jee-Fu Huang, Ming-Jong Bair, Chih-Lang Lin, Chi-Chieh Yang, Sih-Ren Wang, Tsai-Yuan Hsieh, Tzong-Hsi Lee, Pei-Lun Lee, Wen-Chih WuChih-Lin Lin, Wei-Wen Su, Shengshun Yang, Chia-Chi Wang, Jui-Ting Hu, Lien-Juei Mou, Chun-Ting Chen, Yi-Hsiang Huang, Chun-Chao Chang, Jia-Sheng Huang, Guei-Ying Chen, Jian-Neng Gao, Chi-Ming Tai, Chun-Jen Liu, Mei-Hsuan Lee, Pei-Chien Tsai, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wan-Long Chuang, Chiyi Chen, Kuo-Chih Tseng, Ming-Lung Yu

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Journal	Journal of Hepatology
Volume	77
State	Published - 2022

Cite this

Hung, C.-H., Chang, T.-S., Huang, C.-F., Kuo, H.-T., Lo, C.-C., Huang, C.-W., Chong, L.-W., Cheng, P.-N., Yeh, M.-L., Peng, C.-Y., Cheng, C.-Y., Huang, J.-F., Bair, M.-J., Lin, C.-L., Yang, C.-C., Wang, S.-R., Hsieh, T.-Y., Lee, T.-H., Lee, P.-L., ... Yu, M.-L. (2022). Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment naive patients with compensated cirrhosis: real-world experience from Taiwan HCV registry. Journal of Hepatology, 77.

@article{247fe45b58754ae187fcbebc9c8a1b5b,

title = "Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment naive patients with compensated cirrhosis: real-world experience from Taiwan HCV registry",

author = "Chao-Hung Hung and Te-Sheng Chang and Chung-Feng Huang and Hsing-Tao Kuo and Ching-Chu Lo and Chien-Wei Huang and Lee-Won Chong and Pin-Nan Cheng and Ming-Lun Yeh and Cheng-Yuan Peng and Chien-Yu Cheng and Jee-Fu Huang and Ming-Jong Bair and Chih-Lang Lin and Chi-Chieh Yang and Sih-Ren Wang and Tsai-Yuan Hsieh and Tzong-Hsi Lee and Pei-Lun Lee and Wen-Chih Wu and Chih-Lin Lin and Wei-Wen Su and Shengshun Yang and Chia-Chi Wang and Jui-Ting Hu and Lien-Juei Mou and Chun-Ting Chen and Yi-Hsiang Huang and Chun-Chao Chang and Jia-Sheng Huang and Guei-Ying Chen and Jian-Neng Gao and Chi-Ming Tai and Chun-Jen Liu and Mei-Hsuan Lee and Pei-Chien Tsai and Chia-Yen Dai and Jia-Horng Kao and Han-Chieh Lin and Wan-Long Chuang and Chiyi Chen and Kuo-Chih Tseng and Ming-Lung Yu",

year = "2022",

language = "American English",

volume = "77",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

}

Hung, C-H, Chang, T-S, Huang, C-F, Kuo, H-T, Lo, C-C, Huang, C-W, Chong, L-W, Cheng, P-N, Yeh, M-L, Peng, C-Y, Cheng, C-Y, Huang, J-F, Bair, M-J, Lin, C-L, Yang, C-C, Wang, S-R, Hsieh, T-Y, Lee, T-H, Lee, P-L, Wu, W-C, Lin, C-L, Su, W-W, Yang, S, Wang, C-C, Hu, J-T, Mou, L-J, Chen, C-T, Huang, Y-H, Chang, C-C, Huang, J-S, Chen, G-Y, Gao, J-N, Tai, C-M, Liu, C-J, Lee, M-H, Tsai, P-C, Dai, C-Y, Kao, J-H, Lin, H-C, Chuang, W-L, Chen, C, Tseng, K-C & Yu, M-L 2022, 'Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment naive patients with compensated cirrhosis: real-world experience from Taiwan HCV registry', Journal of Hepatology, vol. 77.

TY - JOUR

T1 - Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment naive patients with compensated cirrhosis: real-world experience from Taiwan HCV registry

AU - Hung, Chao-Hung

AU - Chang, Te-Sheng

AU - Huang, Chung-Feng

AU - Kuo, Hsing-Tao

AU - Lo, Ching-Chu

AU - Huang, Chien-Wei

AU - Chong, Lee-Won

AU - Cheng, Pin-Nan

AU - Yeh, Ming-Lun

AU - Peng, Cheng-Yuan

AU - Cheng, Chien-Yu

AU - Huang, Jee-Fu

AU - Bair, Ming-Jong

AU - Lin, Chih-Lang

AU - Yang, Chi-Chieh

AU - Wang, Sih-Ren

AU - Hsieh, Tsai-Yuan

AU - Lee, Tzong-Hsi

AU - Lee, Pei-Lun

AU - Wu, Wen-Chih

AU - Lin, Chih-Lin

AU - Su, Wei-Wen

AU - Yang, Shengshun

AU - Wang, Chia-Chi

AU - Hu, Jui-Ting

AU - Mou, Lien-Juei

AU - Chen, Chun-Ting

AU - Huang, Yi-Hsiang

AU - Chang, Chun-Chao

AU - Huang, Jia-Sheng

AU - Chen, Guei-Ying

AU - Gao, Jian-Neng

AU - Tai, Chi-Ming

AU - Liu, Chun-Jen

AU - Lee, Mei-Hsuan

AU - Tsai, Pei-Chien

AU - Dai, Chia-Yen

AU - Kao, Jia-Horng

AU - Lin, Han-Chieh

AU - Chuang, Wan-Long

AU - Chen, Chiyi

AU - Tseng, Kuo-Chih

AU - Yu, Ming-Lung

PY - 2022

Y1 - 2022

M3 - Journal Article

SN - 0168-8278

VL - 77

JO - Journal of Hepatology

JF - Journal of Hepatology

ER -